Weight-Loss Drugs Show Surprising Ability to Stall Cancer
Wall Street Journal
— · 2min
Plus: GOP lawmakers pull a vote to limit President Trump’s Iran war powers.
And SpaceX postpones the launch of its new Starship rocket.
Daniel Bach hosts.
Sign up for WSJ’s free What’s News newsletter.
Learn more about your ad choices.
Visit megaphone.fm/adchoices
Obesity drugs linked to stalling cancer
- How GLP-1s are more than just weight-loss wonders – but not without risk South China Morning Post —
- Weight-loss drugs from Lilly, Novo linked to stalling cancer: report Seeking Alpha —
- Eli Lilly’s next-gen obesity drug beats Ozempic and Mounjaro, helps patients lose over 30% body weight in trial The Indian Express —
- New weight-loss drug Retatrutide showing stronger results than current options CBS News —
- Experimental drug yields dramatic weight loss Boston Globe —